Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2007
06/26/2007US7235635 IRAK-4: compositions and methods of use
06/26/2007US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
06/26/2007US7235628 Analogues of GLP-1
06/26/2007US7235566 Pyridinone derivatives for treatment of atherosclerosis
06/26/2007US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis
06/26/2007US7235560 Pyrimidine derivative as selective COX-2 inhibitors
06/26/2007US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout
06/26/2007US7235552 Cholenic acid amides and pharmaceutical compositions thereof
06/26/2007US7235549 Benzamide, heteroarylamide and reverse amides
06/26/2007US7235541 Neurokinin antagonists for use as medicaments
06/26/2007US7235532 Angiogenic agents and their uses
06/26/2007US7235525 administering an effective amount of erythropoietin for treatment to a patient with renal failure-associated osteodystrophy or renal failure-associated osteoporosis
06/26/2007US7235371 Human osteoclast derived cathepsin
06/26/2007US7235241 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
06/26/2007CA2216704C Novel peptides and remedy for bone diseases containing the same as active ingredient
06/26/2007CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
06/26/2007CA2185037C Iridaceae extract and compositions containing the same
06/21/2007WO2007070617A1 Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
06/21/2007WO2007070547A2 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
06/21/2007WO2007070546A2 Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
06/21/2007WO2007069712A1 Amine compound and use thereof for medical purposes
06/21/2007WO2007069635A1 Vla-4 inhibitory drug
06/21/2007WO2007069621A1 Novel composition and method for production thereof
06/21/2007WO2007068116A1 Method for correcting a lipid imbalance in a subject
06/21/2007WO2007014238A3 Single dose use of cd20-specific binding molecules
06/21/2007WO2006003388A8 Compositions and methods for treating inflammatory disorders
06/21/2007WO2006002348A8 Solid and crystalline ibandronic acid
06/21/2007WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
06/21/2007US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors
06/21/2007US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate
06/21/2007US20070142465 Macrophage activation inhibitor
06/21/2007US20070142449 Angiogenesis inhibitors
06/21/2007US20070142407 Benzo (1,2,5) thiadiazole als crf-antagonisten
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity
06/21/2007US20070142342 Pharmaceutical compounds
06/21/2007US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ
06/21/2007US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
06/21/2007US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture
06/21/2007US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade
06/21/2007US20070142291 Methods for treating irritable bowel syndrome
06/21/2007US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2)
06/21/2007US20070141039 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome
06/21/2007US20070141020 Use of biocompatible polymers for the preparation of a composition or a medical device
06/21/2007DE60121550T2 Pyrimidin-4-onderivat als LDL-PLA2 Inhibitor Pyrimidin-4-one derivative as LDL-PLA2 inhibitor
06/21/2007CA2667091A1 Method for correcting a lipid imbalance in a subject
06/21/2007CA2633978A1 Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
06/21/2007CA2633957A1 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
06/21/2007CA2633954A1 Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
06/21/2007CA2633374A1 Amine compound and use thereof for medical purposes
06/20/2007EP1798226A1 Triazole derivative
06/20/2007EP1798221A1 2-arylcarboxamide-nitrogeneous heterocycle compound
06/20/2007EP1797869A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation
06/20/2007EP1797033A2 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
06/20/2007EP1796657A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
06/20/2007EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
06/20/2007EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier
06/20/2007EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use
06/20/2007CN1984916A Thienopyridine derivatives, production method and use thereof
06/20/2007CN1984914A Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as protein kinase ingibitor
06/20/2007CN1984667A Medicament for relief of symptoms of joint disorders and inflammatory conditions
06/20/2007CN1982454A Related gene of osteoporosis, its encoded protein and use
06/20/2007CN1981855A Self-emusified composition containing diamond vine extract
06/20/2007CN1981847A Medicinal liquor for treating sprain and contuse
06/20/2007CN1981844A Medicinal liquor for treating wound
06/20/2007CN1981823A Compound preparation for treating extruded lumbar vertebrae disk
06/20/2007CN1981799A Preparing method for extracts of red clover
06/20/2007CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/20/2007CN1321692C Medicinal composition for treating arthritis
06/20/2007CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
06/20/2007CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
06/20/2007CN1321656C Bag for hot-compressing joint
06/20/2007CN1321653C Drink for relaxing muscles and stimulating blood circulation
06/20/2007CN1321644C Process for making substituted pyrazoles
06/20/2007CN1321639C Arthritis therapeutic drug
06/20/2007CN1321632C Compound saussurea involucrata capsule and its preparation process
06/19/2007US7232909 Pyridine derivatives
06/19/2007US7232901 For preparing 2,4-disubstituted pyrrolotriazine compounds
06/19/2007US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives
06/19/2007US7232815 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics
06/19/2007US7232796 Polypeptide for use as a medicament for treating bone defects, bone diseases and for improving bone regeneration
06/19/2007CA2281844C Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
06/14/2007WO2007067088A1 Method for treating complications of rheumatic diseases
06/14/2007WO2007066928A1 Use of the extract of caesalpinia sappan l. and compounds therefrom
06/14/2007WO2007066708A1 INDUCTION OF HARD TISSUE FORMATION RELYING ON Wnt5a/SFRP4 SIGNAL SYSTEM
06/14/2007WO2007066655A1 Equal-containing fermentation product of soybean embryonic axis, and method for production thereof
06/14/2007WO2007066654A1 Fish bone paste, method of producing the same and use thereof
06/14/2007WO2007066340A1 Viscosupplementation with algal polysaccharides in the treatment of arthritis
06/14/2007WO2007066305A1 Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain
06/14/2007WO2007066068A2 Calcium ion channel receptor antagonist
06/14/2007WO2007065349A1 A method for obtaining conjugated estrogen mixtures from pregnant mare urine and the use of a macroporous resin used in the method
06/14/2007WO2007048847A3 Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases
06/14/2007WO2006100213A8 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor
06/14/2007US20070135523 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
06/14/2007US20070135502 Heterocyclic compounds and methods of use
06/14/2007US20070135464 Antiinflammation agents
06/14/2007US20070135459 Substituted 7-aza-quinazoline compounds useful as p38 kinase inhibitors